Samuel J. Reich - Nov 29, 2023 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
Executive Chairman, Director
Signature
/s/ Samuel J. Reich
Stock symbol
SABS
Transactions as of
Nov 29, 2023
Transactions value $
$9,842
Form type
4
Date filed
11/30/2023, 08:00 AM
Previous filing
Mar 16, 2023
Next filing
Feb 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SABS Common Stock Purchase $9.84K +11K +5.29% $0.89 219K Nov 29, 2023 Direct F1, F2
holding SABS Common Stock 548K Nov 29, 2023 Via Big Cypress Holdings LLC
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 11,000 shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), acquired by the reporting person in an open market transaction.
F2 Includes 1,000 shares of Common Stock held jointly by the reporting person and the reporting person's spouse.